Marco Cattaneo. (2023) Aspirin in essential thrombocythemia. For whom? What formulation? What regimen?. Haematologica 108:6, pages 1487-1499.
Crossref
Gregory P. Van Stavern, Loreley D. Smith & Hayley R. James. 2022. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology
7409
7447
.
Alessandro Lucchesi, Roberta Napolitano, Maria Teresa Bochicchio, Giulio Giordano & Mariasanta Napolitano. (2021) Platelets Contribution to Thrombin Generation in Philadelphia-Negative Myeloproliferative Neoplasms: The “Circulating Wound” Model. International Journal of Molecular Sciences 22:21, pages 11343.
Crossref
Gregory P. Van Stavern, Loreley D. Smith & Hayley R. James. 2020. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology
1
40
.
Alessandro Lucchesi, Silvia Carloni, Serena De Matteis, Martina Ghetti, Gerardo Musuraca, Monica Poggiaspalla, Accursio F. Augello, Giulio Giordano, Pier P. Fattori, Giovanni Martinelli & Roberta Napolitano. (2020) Unexpected low expression of platelet fibrinogen receptor in patients with chronic myeloproliferative neoplasms: how does it change with aspirin?. British Journal of Haematology 189:2, pages 335-338.
Crossref
George A. Fritsma. 2020. Rodak's Hematology. Rodak's Hematology
765
792
.
Ivy Altomare & Craig M. Kessler. 2019. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
346
373
.
Samah Alimam & Claire N. Harrison. 2017. Platelets in Thrombotic and Non-Thrombotic Disorders. Platelets in Thrombotic and Non-Thrombotic Disorders
873
886
.
Cecilia Carubbi, Elena Masselli & Marco Vitale. 2017. Platelets in Thrombotic and Non-Thrombotic Disorders. Platelets in Thrombotic and Non-Thrombotic Disorders
589
617
.
Yoshikazu Nagase, Shuji Ueda, Hitomi Matsunaga, Aya Yoshioka, Yoshiyuki Okada, Tomohisa Machida, Keiichi Nakata, Fuka Mima, Risato Takeda, Daisuke Hayashi, Sadaharu Iio, Kohei Okita, Hiroyuki Narahara, Yuichi Yasunaga, Yoshiaki Inui & Sumio Kawata. (2016) Acute compartment syndrome as the initial manifestation of chronic-phase chronic myeloid leukemia: a case report and review of the literature. Journal of Medical Case Reports 10:1.
Crossref
A. Kaifie, M. Kirschner, D. Wolf, C. Maintz, M. H?nel, N. Gattermann, E. G?kkurt, U. Platzbecker, W. Hollburg, J. R. G?thert, S. Parmentier, F. Lang, R. Hansen, S. Isfort, K. Schmitt, E. Jost, H. Serve, G. Ehninger, W. E. Berdel, T. H. Br?mmendorf & S. Koschmieder. (2016) Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry. Journal of Hematology & Oncology 9:1.
Crossref
Catherine Strassel, Lucia Kubovcakova, Pierre H. Mangin, Catherine Ravanat, Monique Freund, Radek C. Skoda, Cécile V. Denis, Arnaud Dupuis, Raoul Herbrecht, Christian Gachet & François Lanza. (2017) Haemorrhagic and thrombotic diatheses in mouse models with thrombocytosis. Thrombosis and Haemostasis 113:02, pages 414-425.
Crossref
Grażyna Gadomska, Danuta Rość, Katarzyna Stankowska, Joanna Boinska, Barbara Ruszkowska-Ciastek & Radosław Wieczór. (2014) Selected parameters of hemostasis in patients with myeloproliferative neoplasms. Blood Coagulation & Fibrinolysis 25:5, pages 464-470.
Crossref
Jamie Koprivnikar & Craig M. Kessler. 2013. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
298
323
.
Argirios E. Tsantes, Georgios K. Nikolopoulos, Panagiotis Tsirigotis, Katerina Zoi, Athanasios Zomas, Violetta Kapsimali, Petros Kopterides, Spyros Chondropoulos, John Dervenoulas & Georgios Mantzios. (2011) Direct evidence for normalization of platelet function resulting from platelet count reduction in essential thrombocythemia. Blood Coagulation & Fibrinolysis 22:6, pages 457-462.
Crossref
Ulrich Budde, Augusto B. Federici & Jacob H. Rand. 2011. Von Willebrand Disease. Von Willebrand Disease
214
230
.
James W. Vardiman. 2011. Hematopathology. Hematopathology
698
732
.
Gregory P. Van Stavern. 2008. Albert & Jakobiec's Principles & Practice of Ophthalmology. Albert & Jakobiec's Principles & Practice of Ophthalmology
4803
4820
.
Craig M. Kessler & Jan Jacques Michiels. 2007. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
295
318
.
Eunmi NamJung Mi KwonSoon Nam LeeSeung Hyun NamKyoung-Eun LeeYeung-Chul MunChu-Myung SeungSe Hoon ParkSoo-Mee BangEun Kyung ChoDong Bok ShinJae Hoon Lee. (2006) Vascular Complications in Patients with Essential Thrombocythemia. The Korean Journal of Hematology 41:3, pages 149.
Crossref
Masanori Umeda, Kimiko Iijima, Chiaki Arai & Masako Katoh. (2004) Therapeutic effectiveness of ranimustine chemotherapy for elderly essential thrombocythemia*. Geriatrics and Gerontology International 4:4, pages 223-228.
Crossref
Claire N Harrison & Anthony R Green. (2003) Essential thrombocythemia. Hematology/Oncology Clinics of North America 17:5, pages 1175-1190.
Crossref
Michelle A Elliott & Ayalew Tefferi. (2003) Thrombocythaemia and pregnancy. Best Practice & Research Clinical Haematology 16:2, pages 227-242.
Crossref
Claire N. Harrison . (2002) Current trends in essential thrombocythaemia. British Journal of Haematology 117:4, pages 796-808.
Crossref
Tiziano Barbui. (2002) What is the standard treatment in essential thrombocythemia. International Journal of Hematology 76:S2, pages 311-317.
Crossref
Connail McCrory & Dagmar Westerling. (2001) Polycythemia Vera Presenting as Complex Regional Pain Syndrome of the Lower Limbs. The Clinical Journal of Pain 17:3, pages 236-238.
Crossref
Morten Krogh Jensen, Peter de Nully Brown, Birgit Villadsen Lund, Ove Juul Nielsen & Hans Carl Hasselbalch. (2001) Increased circulating platelet–leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count. European Journal of Haematology 66:3, pages 143-151.
Crossref
George H. Goldsmith. (2018) Hemostatic Changes in Patients with Malignancy. International Journal of Hematology 73:2, pages 151-156.
Crossref
María Susana Laguna, Laura I. Kornblihtt, Rosana F. Marta, Jan Jacques Michiels & Felisa C. Molinas. (2016) State-of-the-Art Review : Effectiveness of Anagrelide in the Treatment of Symptomatic Patients with Essential Thrombocythemia. Clinical and Applied Thrombosis/Hemostasis 6:3, pages 157-161.
Crossref
Morten Krogh Jensen, Peter De Nully Brown, Birgit Villadsen Lund, Ove Juul Nielsen & Hans Carl Hasselbalch. (2000) Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders. British Journal of Haematology 110:1, pages 116-124.
Crossref
M. Griesshammer, H. Beneke, B. Nussbaumer, M. Grünewald, M. Bangerter & L. Bergmann. (1999) Increased Platelet Surface Expression of P-Selectin and Thrombospondin as Markers of Platelet Activation in Essential Thrombocythaemia. Thrombosis Research 96:3, pages 191-196.
Crossref
S. Bellucci, C. Legrand, B. Boval, L. Drouet & J. Caen. (2001) Studies of platelet volume, chemistry and function in patients with essential thrombocythaemia treated with Anagrelide. British Journal of Haematology 104:4, pages 886-892.
Crossref
S. Willoughby & T.C. Pearson. (1998) The use of aspirin in polycythaemia vera and primary thrombocythaemia. Blood Reviews 12:1, pages 12-22.
Crossref